申请人:——
公开号:US20040014766A1
公开(公告)日:2004-01-22
The present invention is a 1,3,8 substituted xanthine derivative of formula I
1
or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
and R
3
are as defined in the specification.
Compounds of formula I and pharmaceutically acceptable salts or prodrugs thereof show activity as modulators of gluconeogenesis.
本发明涉及一种公式I1的1,3,8取代黄嘌呤衍生物或其药学上可接受的盐,其中R1、R2和R3如规范中所定义。公式I的化合物及其药学上可接受的盐或前药具有调节葡萄糖新生的活性。